Oral GLP-1 pill shows strong weight loss and blood sugar benefits in adults with diabetes A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings from the ATTAIN-2 trial led by a UTHealth Houston researcher.
https://www.news-medical.net/n....ews/20251120/Oral-GL

New trial to test extended tranexamic acid use for faster ACL surgery recovery A breakthrough could be coming in the way young people recover from surgery to reconstruct the anterior cruciate ligament (ACL) in the knee, a common sports injury.
https://www.news-medical.net/n....ews/20251121/New-tri

World’s first experimental lung cancer vaccine to enter clinical trials People at high risk of lung cancer will soon be able to receive the first ever experimental vaccine designed to prevent the disease, in a world-first clinical trial led by researchers at UCL and the University of Oxford.
https://www.news-medical.net/n....ews/20251122/Worlde2

Zanidatamab shows durable and meaningful responses in HER2-positive biliary tract cancer Zanidatamab, a bispecific HER2-targeted antibody, delivered clinically meaningful and durable responses for patients with HER2-positive biliary tract cancer (BTC), according to final results from the HERIZON-BTC-01 clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
https://www.news-medical.net/n....ews/20251125/Zanidat

SISAQOL-IMI provides guidance for implementing patient-reported outcomes in cancer clinical trials The SISAQOL-IMI consortium, co-led by the European Organisation for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), just announced the publication of its pivotal paper in The Lancet Oncology outlining how its recommendations for patient-reported outcomes (PROs) in cancer clinical trials were developed.
https://www.news-medical.net/n....ews/20251126/SISAQOL